Related references
Note: Only part of the references are listed.Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update
Monica R. Gadelha et al.
ENDOCRINE REVIEWS (2019)
Somatostatin Analogs and Glucose Metabolism in Acromegaly: A Meta-Analysis of Prospective Interventional Studies
Alessia Cozzolino et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Ethnic differences in glucose effectiveness and disposition index in overweight/obese African American and white women with prediabetes: A study of compensatory mechanisms
Kwame Osei et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2017)
Diabetes in Patients With Acromegaly
A. M. Hannon et al.
CURRENT DIABETES REPORTS (2017)
Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: a study in 148 patients
Orsalia Alexopoulou et al.
PITUITARY (2014)
Prevalence of diabetes mellitus in patients with acromegaly
A. V. Dreval et al.
ENDOCRINE CONNECTIONS (2014)
Assessment of Pancreatic β-Cell Function: Review of Methods and Clinical Applications
Eugenio Cersosimo et al.
CURRENT DIABETES REVIEWS (2014)
Insulin-like growth factor-I correlates more closely than growth hormone with insulin resistance and glucose intolerance in patients with acromegaly
Dan Niculescu et al.
PITUITARY (2013)
Elevated plasma glucose-dependent insulinotropic polypeptide associates with hyperinsulinemia in metabolic syndrome
Salvatore Calanna et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Impaired glucose metabolism in Japanese patients with acromegaly is restored after successful pituitary surgery if pancreatic β-cell function is preserved
Yuka Kinoshita et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
BOTH INSULIN RESISTANCE AND INSULIN SECRETION ARE INVOLVED IN THE PRE-DIABETES OF ACROMEGALY
D. Niculescu et al.
ACTA ENDOCRINOLOGICA-BUCHAREST (2010)
Disposition Index, Glucose Effectiveness, and Conversion to Type 2 Diabetes The Insulin Resistance Atherosclerosis Study (IRAS)
Carlos Lorenzo et al.
DIABETES CARE (2010)
Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) study
R. A. DeFronzo et al.
DIABETOLOGIA (2010)
Skeletal Muscle Mass in Acromegaly Assessed by Magnetic Resonance Imaging and Dual-Photon X-Ray Absorptiometry
Pamela U. Freda et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Effects of Somatostatin Analogs on Glucose Homeostasis: A Metaanalysis of Acromegaly Studies
Gherardo Mazziotti et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Short-term impact on glycemic control of partial removal of the tumor mass by transsphenoidal surgery for naive GH-secreting pituitary macroadenomas
D. Niculescu et al.
ACTA ENDOCRINOLOGICA-BUCHAREST (2008)
Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study
M. Laakso et al.
DIABETOLOGIA (2008)
Relationship between disease-related morbidity and biochemical markers of activity in patients with acromegaly
JJ Puder et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery
EV Polyzogopoulou et al.
DIABETES (2003)
Insulin action on protein metabolism in acromegalic patients
A Battezzati et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2003)
Impaired β-cell function in the presence of reduced insulin sensitivity determines glucose tolerance status in acromegalic patients
S Kasayama et al.
CLINICAL ENDOCRINOLOGY (2000)
Share Paper
